Provided by Tiger Trade Technology Pte. Ltd.

Edgewise Therapeutics, Inc.

40.12
-0.4850-1.19%
Volume:199.04K
Turnover:8.04M
Market Cap:4.36B
PE:-21.68
High:41.25
Open:40.39
Low:39.89
Close:40.60
52wk High:48.51
52wk Low:14.25
Shares:108.60M
Float Shares:88.17M
Volume Ratio:0.31
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8502
EPS(LYR):-1.6302
ROE:-38.03%
ROA:-25.03%
PB:9.72
PE(LYR):-24.61

Loading ...

Edgewise Therapeutics Advances EDG-7500 to Phase 3 Following 'Positive' HCM Data

MT Newswires Live
·
Jun 16

Edgewise Therapeutics Shares Down 26.3% Premarket After Co Reports Heart Disease Drug Mid-Stage Trial Data

THOMSON REUTERS
·
Jun 16

Edgewise says EDG-7500 posts positive 12-week Phase 2 data in hypertrophic cardiomyopathy trial

Reuters
·
Jun 16

Edgewise Therapeutics Announces Positive Top-Line Data From 12-Week Phase 2 Cirrus-HCM Trial With Edg-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

THOMSON REUTERS
·
Jun 16

Edgewise Therapeutics - No Lvef Reductions Below 50% Observed With Edg-7500

THOMSON REUTERS
·
Jun 16

Edgewise Therapeutics - to Initiate Phase 3 Edg-7500 Program in Q4 2026

THOMSON REUTERS
·
Jun 16

Do New Analyst Upgrades and Option Grants Clarify Edgewise Therapeutics' (EWTX) Long-Term Story?

Simply Wall St.
·
Jun 08

Edgewise Therapeutics Shareholders Back Board and Governance

TIPRANKS
·
Jun 06

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Fate Therapeutics (FATE) and Edgewise Therapeutics (EWTX)

TIPRANKS
·
Jun 06

Edgewise Therapeutics price target raised to $53 from $45 at JPMorgan

TIPRANKS
·
Jun 05

U.S. RESEARCH ROUNDUP-Chipotle Mexican Grill, Honeywell, Tesla

Reuters
·
Jun 05

Edgewise Therapeutics Reports Inducement Grants As Permitted By Nasdaq Listing Rules

Reuters
·
Jun 04

EdgeX offers USDC payments after EDGE liquidations spark scrutiny

cryptonews
·
Jun 04

Edgewise Therapeutics grants 74,000 inducement stock options at $34.16 per share

Reuters
·
Jun 04

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

THOMSON REUTERS
·
Jun 04

Edgewise Therapeutics price target lowered to $48 from $50 at RBC Capital

TIPRANKS
·
Jun 02

Edgewise Therapeutics price target raised to $45 from $42 at H.C. Wainwright

TIPRANKS
·
Jun 02

Edgewise Therapeutics Is Maintained at Outperform by Wedbush

Dow Jones
·
Jun 02

Deals of the day-Mergers and acquisitions

Reuters
·
Jun 02

U.S. RESEARCH ROUNDUP-Edgewise Therapeutics, IBM, Rubrik

Reuters
·
Jun 02